Publications
- Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidlines related to the diagnostics and treatment of dyslipidemias issued in 2011 +32013 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Statin therapy in patients with acute coronary syndrome2012 | First Faculty of Medicine
- The effect of simvastatin and fenofibrate on the expression of leukocyte adhesion molecules and lipopolysaccharide receptor CD14 in type 2 diabetes mellitus2012 | First Faculty of Medicine
- Lipid-lowering treatment in metabolic syndrome2009 | First Faculty of Medicine
- Rosuvastatine2009 | First Faculty of Medicine
- Pharmacogenetics of statin treatment - can it be tailored?2009 | First Faculty of Medicine
- Statin pharmacokinetics2008 | First Faculty of Medicine
- Impact of apolipoprotein A5 gene variants of statin treatment efficacyPublication without faculty affiliation
- 2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, Central Library of Charles University, Second Faculty of Medicine
- Statement CSAT on Consensus statement of the European Atherosclerosis Society: Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis2023 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové, Central Library of Charles University
Loading network view...
